Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Debt Ratio (2016 - 2025)

Adma Biologics (ADMA) has disclosed Debt Ratio for 12 consecutive years, with 0.12 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 21.93% year-over-year to 0.12, compared with a TTM value of 0.12 through Dec 2025, down 21.93%, and an annual FY2025 reading of 0.12, down 21.93% over the prior year.
  • Debt Ratio was 0.12 for Q4 2025 at Adma Biologics, down from 0.13 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.47 in Q2 2022 and bottomed at 0.12 in Q4 2025.
  • Average Debt Ratio over 5 years is 0.33, with a median of 0.4 recorded in 2021.
  • The sharpest move saw Debt Ratio surged 459.41% in 2021, then crashed 62.69% in 2024.
  • Year by year, Debt Ratio stood at 0.34 in 2021, then rose by 19.36% to 0.41 in 2022, then fell by 3.21% to 0.4 in 2023, then plummeted by 62.69% to 0.15 in 2024, then dropped by 21.93% to 0.12 in 2025.
  • Business Quant data shows Debt Ratio for ADMA at 0.12 in Q4 2025, 0.13 in Q3 2025, and 0.13 in Q2 2025.